Creative Planning
MIRM icon

Creative Planning’s Mirum Pharmaceuticals MIRM Stock Holding History

Creative Planning’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Sell
30,352
-303
-1% -$30.4K ﹤0.01% 1661
2026
Q1 		$2.83M Sell
30,655
-864
-3% -$81.3K ﹤0.01% 1622
2025
Q4 		$2.49M Buy
31,519
+18,775
+147% +$1.35M ﹤0.01% 1544
2025
Q3 		$934K Buy
12,744
+3,527
+38% +$224K ﹤0.01% 2175
2025
Q2 		$469K Sell
9,217
-134
-1% -$5.97K ﹤0.01% 2519
2025
Q1 		$421K Buy
9,351
+1,221
+15% +$57.6K ﹤0.01% 2456
2024
Q4 		$336K Buy
8,130
+1,748
+27% +$72.8K ﹤0.01% 2565
2024
Q3 		$249K Buy
+6,382
New +$255K ﹤0.01% 2685

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Planning's MIRM Position: Q2 2026 in Review

Creative Planning reduced its Mirum Pharmaceuticals (MIRM) stake by 0.99% in Q2 2026, selling an estimated $30.4K and leaving 30,352 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

Creative Planning first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Creative Planning held 30,352 shares of Mirum Pharmaceuticals worth $3.55M as of Q2 2026.
  • Creative Planning sold 303 Mirum Pharmaceuticals shares in Q2 2026, an estimated $30.4K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1661 holding.
  • Creative Planning first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.